ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Health Technology

Sysmex Corp.

Business Summary

Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.

Financial Highlights

Mar 2022 JPYUSD
Revenue363,780M3,237.26M
Gross Profit190,585M1,696.00M
Operating income69,566M619.06M
Income before tax67,907M604.30M
Net income44,092M392.37M
EBITDA96,997M863.17M
Diluted EPS210.491.87
Dividends Per Share760.67
Total Assets483,707M3,985.22M
Total liabilities134,898M1,111.41M
Total equity348,303M2,869.64M
Operating cash flow58,739M522.71M
Currency in JPYCurrency in USD

Historical Data

 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 281,935M 293,506M 301,980M 305,073M 363,780M
Gross Profit 158,949M 161,607M 159,807M 154,303M 190,585M
Operating income 59,947M 60,799M 54,501M 49,165M 69,566M
Income before tax 58,117M 57,955M 49,433M 49,334M 67,907M
Net income 39,221M 41,224M 34,882M 31,904M 44,092M
EBITDA 74,590M 76,641M 78,456M 74,581M 96,997M
Diluted EPS 187.84 197.28 166.92 152.47 210.49
Dividends Per Share 66 70 72 72 76
Total Assets 321,979M 346,775M 389,291M 424,895M 483,707M
Total liabilities 80,531M 81,588M 110,941M 118,955M 134,898M
Total equity 240,750M 264,449M 277,684M 305,318M 348,303M
Operating cash flow 52,240M 44,743M 53,182M 56,873M 58,739M
 Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022
Revenue 2,543.79M 2,646.70M 2,777.44M 2,876.48M 3,237.26M
Gross Profit 1,434.13M 1,457.30M 1,469.81M 1,454.90M 1,696.00M
Operating income 540.87M 548.25M 501.27M 463.56M 619.06M
Income before tax 524.36M 522.61M 454.65M 465.16M 604.30M
Net income 353.87M 371.74M 320.82M 300.81M 392.37M
EBITDA 672.99M 691.11M 721.59M 703.21M 863.17M
Diluted EPS 1.69 1.77 1.53 1.43 1.87
Dividends Per Share 0.59 0.63 0.66 0.67 0.67
Total Assets 3,027.54M 3,132.99M 3,606.04M 3,845.20M 3,985.22M
Total liabilities 757.22M 737.11M 1,027.65M 1,076.51M 1,111.41M
Total equity 2,263.75M 2,389.20M 2,572.21M 2,763.05M 2,869.64M
Operating cash flow 471.34M 403.47M 489.13M 536.24M 522.71M

Valuation Measures

Mar 2022
PER42.31
ROA9.70%
ROE13.49%
Operating margin19.12%
Profit margin12.12%

Key executives

  • Chairman, Chief Executive Officer & President: Hisashi Ietsugu
  • Director, CTO & COO-LS Business Unit: Kaoru Asano
  • CFO, Director & Senior Managing Executive Officer: Yukio Nakajima
  • Manager-Informatics: Yasuhiro Takachi
  • Executive Officer: Keiji Fujimoto

Shareholders

  • Baillie Gifford & Co. (5.9%)
  • Kobe Yamabuki Foundation (5.7%)
  • Nakatani Foundation (5.6%)
  • Nakatani Kosan YK (4.9%)
  • IETSUGU KAZUKO (2.9%)
  • WADA TAEKO (2.9%)
  • BlackRock Fund Advisors (2.7%)
  • Nomura Asset Management Co., Ltd. (2.7%)
  • The Vanguard Group, Inc. (2.3%)
  • IETSUGU FAMILY (2.2%)

Contact Details

  • Website:http://www.sysmex.co.jp
  • Address: 1-5-1 Wakinohama-Kaigandori, Chuo-Ku, Kobe, 651-0073, Japan
  • Phone: +81.78.265.0500

Related Companies

  • Sysmex Pilot Co. Ltd.
  • Sysmex Astrego AB
  • Oxford Gene Technology (Operations) Ltd.
  • Astrego Diagnostics AB
  • Sysmex Medical Electronics (Shanghai) Co., Ltd.
  • Sysmex Wuxi Co. Ltd.
  • Sysmex Inostics, Inc.
  • Sysmex Turkey Diagnostik Sistemleri Ltd. STI
  • Sysmex (Malaysia) Sdn.Bhd.
  • Sysmex Vietnam Co. Ltd.
  • Sysmex Taiwan Co. Ltd.
  • Sysmex Suisse AG
  • Sysmex Slovakia sro
  • Sysmex Shanghai Ltd.
  • Sysmex RUS LLC
  • Sysmex Polska Sp zoo
  • Sysmex Philippines, Inc.
  • Sysmex Hungaria Kft.
  • Sysmex Hong Kong Ltd.
  • Sysmex Espana SL
  • Sysmex do Brasil Industria e Comercio Ltda.
  • Sysmex CZ sro
  • Sysmex Canada, Inc.
  • Sysmex Austria GmbH
  • Sysmex Middle East FZ LLC
  • Sysmex South Africa (Pty) Ltd.
  • Sysmex Inostics GmbH
  • Sysmex Korea Co., Ltd.
  • Katakura Industries Co. Ltd. /Biological Research Center/
  • Sysmex RA Co. Ltd.

Competitors

  • Guardant Health, Inc.
  • General Biologicals Corp.
  • Haemonetics Corporation
  • Exact Sciences Corporation
  • Biocept, Inc.
  • SD Biosensor, Inc.
  • Epigenomics AG
  • Hangzhou Biotest Biotech Co., Ltd. Class A
Last Updated on 4 Oct, 2022

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more